As of 2026-10-20, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -1.41 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.67 USD, the upside of Aldeyra Therapeutics Inc is -312.22%.
Based on its market price of 0.67 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 312.22%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.41 - -1.41 | -1.41 | -312.22% |
| P/E | (6.16) - (7.65) | (7.41) | -1214.2% |
| DDM - Stable | (2.35) - (7.62) | (4.99) | -850.1% |
| DDM - Multi | (0.13) - (0.33) | (0.19) | -128.5% |
| Market Cap (mil) | 54.31 |
| Beta | 2.64 |
| Outstanding shares (mil) | 81.66 |
| Enterprise Value (mil) | 9.22 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.86% |
| Cost of Debt | 5.00% |
| WACC | 8.56% |